The organisers invite you to the 18th SCI/RSC Medicinal Chemistry Symposium, Europe's premier biennial Medicinal Chemistry event, focusing on first disclosures and new strategies in medicinal chemistry. Reflecting current trends in medicinal chemistry and pharmaceutical research, the theme of the conference will be 'Drugging the Undruggable'.
The scientific programme will feature lectures on Enzyme Inhibitors, Ligands for Receptors and Ion Channels plus a Hot Topic late breaker session. In addition the meeting has a number of talks addressing key Enabling Processes and Technologies for the future of Medicinal Chemistry.
Helen Gibb (send an email)
Removing pathogenic proteins from cells - a new therapeutic paradigm for drug discovery.
The search for LRRK2 kinase inhibitors: progressing a novel target for Parkinson's Disease from GWAS towards the clinic.
How to get a late checkout: residence time in the discovery of enzyme inhibitors.
The discovery of the first, designed for inhalation, prostacyclin receptor agonist for pulmonary arterial hypertension.
Discovery and characterization of selective spleen tyrosine kinase inhibitors for the treatment of rheumatoid arthritis.
Fragment-based discovery of novel inhibitors of Lp-PLA2.
Discovery of compounds which modulate utrophin expression for the therapy of Duchenne muscular dystrophy (DMD).
Delegate fees will be announced on our website in the Autumn.